Association between CYP2C19 extensive metabolizer phenotype and childhood anti-reflux surgery following failed proton pump inhibitor medication treatment-Reference-Cited by-同舟云学术

Association between CYP2C19 extensive metabolizer phenotype and childhood anti-reflux surgery following failed proton pump inhibitor medication treatment

Published:2017-12-06 Issue:1 Volume:177 Page:69-77
ISSN:0340-6199
Container-title:European Journal of Pediatrics
language:en
Short-container-title:Eur J Pediatr

Author:

Franciosi James P.^ORCID,Mougey Edward B.,Williams Andre,Gomez Suarez Roberto A.,Thomas Cameron,Creech Christa L.,George Katherine,Corao Diana,Lima John J.

Funder

Nemours Research Foundation

Publisher

Springer Science and Business Media LLC

Subject

Pediatrics, Perinatology and Child Health

Link

http://link.springer.com/article/10.1007/s00431-017-3051-4/fulltext.html

Reference43 articles.

1. Baldwin RM, Ohlsson S, Pedersen RS, Mwinyi J, Ingelman-Sundberg M, Eliasson E, Bertilsson L (2008) Increased omeprazole metabolism in carriers of the CYP2C19*17 allele; a pharmacokinetic study in healthy volunteers. Br J Clin Pharmacol 65(5):767–774. https://doi.org/10.1111/j.1365-2125.2008.03104.x

2. Benkov K, Lu Y, Patel A, Rahhal R, Russell G, Teitelbaum J, NASPGHAN Committee on Inflammatory Bowel Disease (2013) Role of thiopurine metabolite testing and thiopurine methyltransferase determination in pediatric IBD. J Pediatr Gastroenterol Nutr 56(3):333–340. https://doi.org/10.1097/MPG.0b013e3182844705

3. Cao W, Hashibe M, Rao JY, Morgenstern H, Zhang ZF (2003) Comparison of methods for DNA extraction from paraffin-embedded tissues and buccal cells. Cancer Detect Prev 27(5):397–404. https://doi.org/10.1016/S0361-090X(03)00103-X